River Road Asset Management, an investment management company released its “River Road Large Cap Value Select Fund” Q4 2024 ...

A software engineer with two decades of mastery, Sarah was the backbone of her company — until her firm traded network infrastructure for AI-driven systems. Now, in her 40s, she’s reskilling from ...

As the waves of tech innovation ripple through our economy and society, it’s going to create unfathomable opportunities. But ...

The 2025 College Basketball Crown is set to get underway on Monday in Las Vegas. That means it's time for college hoops fans to break out their pens and paper and fill out their brackets before ...

Wave Life Sciences (WVE) shares ended the last trading session 6.1% higher at $10.02. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

Making smart investing moves in the economy is a tall order, but if you don’t want to drown in spreadsheets and charts, it takes a degree to understand; Sterling Stock Picker makes things simple.

Passive investing has done a great job for a lot of investors over the last decade. If you bought a global index fund you ended up with a lot of exposure to the US, and a lot of exposure to big tech.

Alyx Wood, chief investment officer of UK-focused hedge fund Kernow Asset Management, joins Merryn this week. We discuss his contrarian approach to investing, where he is short, where he is long ...

Wave Life's WVE-N531 met all Phase 2 goals, showing exon skipping, dystrophin restoration. The therapy showed a 28.6% muscle fibrosis reduction, a 50% CK decline, and decreased IL-6/MCP-1 ...

Wave Life Sciences (NASDAQ:WVE) announced Wednesday its plans to file a New Drug Application (NDA) with the U.S. FDA in 2026 to seek the regulator’s accelerated approval for WVE-N531, an ...

Barron's reporters have screened for potentially attractive stocks based on a variety of metrics. Here are the stocks they have identified for investors to research further. Barron's reporters ...